Tag
NYSE: LLY
- Nektar Therapeutics wins US$90M jury award in Lilly licence case
- Eli Lilly and Company wins FDA approval for weekly Onswik insulin
- Eli Lilly and Company wins FDA pediatric Olumiant approval for severe alopecia
- Eli Lilly says Foundayo draws one‑third of new GLP‑1 pill patients
- Scribe Therapeutics develops one‑time cholesterol treatment without permanent gene editing
- Amplia signs Eli Lilly collaboration for Phase 1b/2b lung cancer trial
- Artificial Intelligence and the invisible revolution: A Mugglehead roundup
- Health Canada approves Zepbound for obstructive sleep apnea in adults with obesity
- Lung cancer innovations showcased at ASCO 2026 as researchers pursue earlier detection
- Novartis advances actinium-based cancer drug after promising trial data
- AI‑designed drugs near human trials as AlphaFold enters clinical phase
- Eli Lilly inks USD$2.75B AI drug deal with Insilico Medicine
- Epilepsy drug reduces sleep apnea symptoms by up to 50 per cent in clinical trial
- Illumina partners with pharma giants to map disease biology at unprecedented scale
- AI‑powered lung cancer detection debuts at Topeka’s St. Francis Hospital
- Akero Therapeutics nearly doubles stock price on positive clinical studies
- Vivos Therapeutics new device could provide substantial relief for migraine sufferers